Reference health

Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome

https://doi.org/10.1210/jc.2004-1045
CiteStamped reference-health badge
35/35 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 35 checked references that resolve
resolves10.1210/jcem-57-2-356
Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease*
resolves10.2337/diab.41.10.1257
Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome
resolves10.1210/endo-123-2-733
Insulin-Like Growth Factor I and Insulin Potentiate Luteinizing Hormone-Induced Androgen Synthesis by Rat Ovarian Thecal-Interstitial Cells*
resolves10.1172/JCI114745
Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells.
resolves10.1016/0002-9343(83)90653-8
Mediators of postreceptor action of insulin
resolves10.1056/NEJM199608293350902
Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
resolves10.1016/S0002-9343(99)80057-6
Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus
resolves10.2337/diacare.22.1.141
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
resolves10.2337/diab.37.12.1595
Role of Insulin Resistance in Human Disease
resolves10.2337/diacare.14.3.195
Insulin Resistance, Hyperinsulinemia, Hypertriglyceridemia, and Hypertension: Parallels Between Human Disease and Rodent Models
resolves10.1056/NEJM198903163201105
Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose Tolerance
resolves10.1016/S0002-9149(99)00211-8
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome
resolves10.2337/diacare.26.10.2796
Low Insulin Sensitivity (<i>S</i>i = 0) in Diabetic and Nondiabetic Subjects in the Insulin Resistance Atherosclerosis Study
resolves10.1161/circ.106.25.3143
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
resolves10.2337/diab.41.6.715
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
resolves10.2337/diacare.24.4.683
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
resolves10.1093/oxfordjournals.aje.a009572
Syndrome X and Mortality: A Population-based Study
resolves10.1001/jama.287.3.356
Prevalence of the Metabolic Syndrome Among US Adults
resolves10.1016/S0015-0282(03)00347-9
The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study
resolves10.1016/S0026-0495(03)00104-5
Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome
resolves10.1016/S0015-0282(02)03153-9
Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated
resolves10.1016/0002-9378(83)90091-1
Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: A common endocrinopathy with distinct pathophysiologic features
resolves10.1038/sj.ijo.0801994
Obesity and the polycystic ovary syndrome
resolves10.2337/diacare.26.3.575
A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
resolves10.2337/diacare.20.7.1183
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
resolves10.2337/diacare.21.4.518
Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994
resolves10.2337/diacare.26.11.3160
Follow-up Report on the Diagnosis of Diabetes Mellitus
resolves10.3109/00016349209006227
Polycystic ovary syndrome and risk for myocardial infarction: Evaluated from a risk factor model based on a prospective population study of women
resolves10.1056/NEJM198911093211907
High-Density Lipoprotein — The Clinical Implications of Recent Studies
resolves10.1074/jbc.M110985200
High Density Lipoprotein Binding to Scavenger Receptor, Class B, Type I Activates Endothelial Nitric-oxide Synthase in a Ceramide-dependent Manner
resolves10.1172/JCI200418004
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
resolves10.1038/89986
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase
resolves10.1210/jc.2002-020557
The Biological Variation of Testosterone and Sex Hormone-Binding Globulin (SHBG) in Polycystic Ovarian Syndrome: Implications for SHBG as a Surrogate Marker of Insulin Resistance
resolves10.1210/jcem-73-3-590
Acanthosis Nigricans, Insulin Action, and Hyperandrogenism: Clinical, Histological, and Biochemical Findings*
resolves10.2337/diabetes.52.8.2160
Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies
The 6 references without a DOI — listed, not checked
no DOI — not checkedPrevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
no DOI — not checkedCellular mechanisms of insulin resistance in polycystic ovarian syndrome.
no DOI — not checkedInsulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.
no DOI — not checkedPrevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
no DOI — not checkedU.S. Department of Health and Human Services (DHHS)
no DOI — not checkedDiagnostic criteria for polycystic ovary syndrome: towards a rational approach
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1210/jc.2004-1045"><img src="https://citestamp.com/citestamped/10.1210/jc.2004-1045/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1210/jc.2004-1045/badge.svg)](https://citestamp.com/citestamped/10.1210/jc.2004-1045)